Fig. 4
From: Changes of N6-methyladenosine modulators promote breast cancer progression
Use of bc-GenExMiner 4.0 database to compare the mRNA expression of m6A enzymes in BC patients by clinicopathologic parameters. (a-e) Global significant difference between groups was assessed by Welch’s test, followed by Dunnett-Tukey-Kramer test for pairwise comparison. * P < 0.05; ** P < 0.01; *** P < 0.001